Siegfried Holding AG

Overview

Siegfried Holding AG (Siegfried) is a life science company. It is active in the primary and secondary production of drugs. The company develops and manufactures active pharmaceutical ingredients (APIs). It manufactures APIs for the research-based pharmaceutical industry and corresponding intermediates and controlled substances. The company also offers development and production services for finished dosage forms including sterile filling. Siegfried has production facilities in the USA, Switzerland, Malta, China, Germany, and France. The company also offers its products in USA Europe and other countries. Siegfried is headquartered in Zofingen, Aargau, Switzerland.
Key Stats
Address
Untere Bruehlstrasse 4, Zofingen, Switzerland
Headquarters

Switzerland

Contact

41 62 7461111

Website
siegfried.ch
No of Employees

3,432

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

SFZN [SWF]

Revenue (2020)

$900 m

7.3% (2020 vs 2019)
Net Income (2020)

$65 m

21.5% (2020 vs 2019)
Net Profit Margin

7 %

12.9% (2020 vs 2019)
Market Cap *

$3,924 m

EPS *

$8.1

  *Note: Ratios based on the share price as of 6-October-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Siegfried Holding AGPerrigo Co PlcLonza Group LtdBachem Holding AG
Key Information
Headquarters Switzerland Ireland Switzerland Switzerland
Headquarter City Zofingen Dublin Basel Bubendorf
Headquarter State/Province - - - -
No. of Employees 3,432 11,500 14,405 1,580
Entity Type Public Public Public Public

Products & Services

Siegfried is the global industry leading custom manufacturing organization. The company's major products and services include the following:

Products
  • Drug Substance:
  • API
  • Intermediates
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Services
  • Contract Manufacturing:
  • Analytical Services
  • API Chemical
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Irene Wosgien Chief Operating Officer - Drug Substances Senior Management 2021 48 Ms. Irene Wosgien has been the Chief Business Officer of Siegfried since 2021. Prior to this, she served various management positions...
Wolfgang Wienand Ph.D. Chief Executive Officer Senior Management 2019 49 Dr. Wolfgang Wienand has been the Chief Executive Officer of Siegfried since January 2019. Previously, he served as the Head...
Jurgen Roos, Ph.D. Chief Scientific Officer Senior Management 2019 53 Mr. Jurgen Ross has been the Chief Scientific Officer of the company since April 2019. Prior to this, he served...
Reto Suter, Ph.D. Chief Financial Officer Senior Management 2017 50 Dr. Reto Suter has been the Chief Financial Officer of Siegfried since May 2017. Prior to this, he served as...
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2020 Plans/Strategy In October, the company announced its plans to acquire two plants in El Masnou and…
2020 Contracts/Agreements In September, the company announced that it has signed a cooperation and supply agreement with…
2018 Acquisitions/Mergers/Takeovers In March, Siegfried acquired the drug product manufacturing facility from Arena Pharmaceuticals GmbH in Zofingen,…
2017 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2017 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2016 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


Penick LLC

Address

33 Industrial Park Road, Pennsville
United States of America

Telephone

1 856 6783601

Website

www.penickcorp.com
Siegfried Generics (Malta) Ltd

Address

HHF070 Hal Far Industrial Estate, P.O. Box 14, Hal Far BBG 07
Malta

Telephone

356 222 77711

Siegfried (USA), Inc.

Address

33 Industrial Park Road, Pennsville
United States of America

Telephone

1 877 763 8630

Website

www.siegfried-usa.com
Siegfried (Nantong) Pharmaceuticals Co Ltd

Address

No. 5, Tongshun Road, NETDA, Nantong
China

Telephone

86 513 89183000

Website

www.siegfried.cn
Siegfried Hameln GmbH

Address

Langes Feld 13, Hameln
Germany

Telephone

49 5151 581000

Website

www.pharma-hameln.de

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
29 Sep 2020 Siegfried Acquires Two Pharmaceutical Manufacturing Sites from Novartis Asset Transaction Siegfried Holding AG Novartis AG
29 Sep 2015 Siegfried Holding Raises USD61.33 Million in Bonds Offering Debt Offering RAG-Stiftung Siegfried Holding AG
07 May 2015 Siegfried Acquires API Businesses from BASF Asset Transaction Siegfried Holding AG BASF SE

Jobs Overview

96

Active Jobs

37

Posted

11

Closed

Job Trends

Latest Jobs

Job title Company Country
Site Controller Siegfried Holding AG Switzerland
Quality analysis laboratory assistant (m / f / d) Siegfried Holding AG Germany
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar